Why the study?
Does intravenous insulin improve clinical outcomes in patients with acute myocardial infarction and hyperglycemia?
Population
Patients with acute myocardial infarction admitted to intensive care and those with unspecified hyperglycemia
Design
Review
Authors
Loading...
Intravenous insulin effects beyond glucose control remain unproven for AMI or ICU hyperglycemia; leaves open need for isolating trials before any practice consideration.
Does intravenous insulin improve clinical outcomes in patients with acute myocardial infarction and hyperglycemia?
Insulin may offer therapeutic benefits in acute myocardial infarction and critical illness beyond glucose control by modulating inflammation and free fatty acid metabolism.
Dandona et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: